×
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF
$ 40.00
Relapse Prevention and Residual Symptoms: A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, and Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Mixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study PDF
$ 40.00
Mixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study PDF quantity
$ 40.00
×
Serum Lipoproteins Improve After Successful Pharmacologic Antidepressant Treatment: A Randomized Open-Label Prospective Trial PDF
$ 40.00
Serum Lipoproteins Improve After Successful Pharmacologic Antidepressant Treatment: A Randomized Open-Label Prospective Trial PDF quantity
$ 40.00
×
Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes PDF
$ 40.00
Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes PDF quantity
$ 40.00
×
Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications PDF
$ 40.00
Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
